Press Release: Allient Inc. Delivers Revenue Growth, Margin Expansion and Meaningful Deleveraging in Fourth Quarter and Full-Year 2025

Dow Jones05:23
   --  Fourth quarter results reflect revenue growth, margin expansion and 
      order momentum 
 
          --  Revenue increased 17% to $143.4 million, including 15% organic 
             growth on a constant currency basis; orders rose 9% sequentially, 
             with book-to-bill of 1.01 
 
          --  Gross margin expanded 90 basis points to 32.4%, while operating 
             income increased 76% to $11.4 million, or 7.9% of revenue, up 260 
             basis points 
 
          --  Diluted EPS was $0.38, more than double the prior year, with 
             adjusted EPS of $0.55; Adjusted EBITDA increased 35% to $19.0 
             million, with the margin expanding 170 basis points to 13.3% 
 
 
 
   --  2025 performance demonstrates disciplined execution and strengthened 
      financial position 
 
          --  Revenue totaled $554.5 million, up 5%, with record gross margin 
             of 32.8%, expanding 150 basis points; operating income increased 
             46% to $44.0 million 
 
          --  Simplify to Accelerate NOW program identified and initiated 
             actions to deliver over $6 million in annualized savings in 2025 
 
 
          --  Generated a record $56.7 million of cash from operations, up 35% 
             year-over-year 
 
          --  Net debt declined by $48.4 million year-over-year, with the 
             leverage ratio improving significantly to 1.82x, as described in 
             the reconciliation of non-GAAP financial measures 
 
 
BUFFALO, N.Y.--(BUSINESS WIRE)--March 05, 2026-- 

Allient Inc. (Nasdaq: ALNT) ("Allient" or the "Company"), a global designer and manufacturer of precision and specialty Motion, Controls and Power products and solutions for targeted industries and applications, today reported financial results for its fourth quarter and year ended December 31, 2025.

"2025 was an important year for Allient as we delivered strong performance in the fourth quarter and meaningful improvement across key financial metrics for the full year," commented Dick Warzala, Chairman and CEO. "Our 17% revenue growth in the fourth quarter, combined with strong operating leverage, reflects increased demand in our served Industrial Markets and disciplined execution across our other targeted growth verticals. The continued benefits of our Simplify to Accelerate NOW initiative drove operational efficiencies, contributing to sustainable margin expansion. For the full year, we achieved record gross margin of 32.8%, increased operating income 46%, and generated record cash from operations of $56.7 million, reflecting improved earnings and working capital discipline."

Mr. Warzala continued, "We also made significant progress strengthening the balance sheet, reducing net debt by $48.4 million and improving leverage to 1.82x. This improved leverage profile provides additional capacity to invest in organic growth initiatives, support new program launches and pursue disciplined capital allocation opportunities.

"Looking ahead to 2026, we believe we are well positioned to build on this momentum. Order trends exiting the year, improving automation demand and continued traction in power quality solutions supporting data center infrastructure reinforce our confidence in the secular drivers of electrification, automation and energy efficiency. While we remain mindful of macroeconomic variability in certain end markets, our diversified portfolio, improved cost structure and enhanced financial flexibility support disciplined growth and long-term value creation."

Fourth Quarter 2025 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue increased 17%, or $21.3 million, to $143.4 million, reflecting increased demand in the Industrial market and solid performance across several of the Company's targeted growth verticals. Foreign currency translation provided a favorable impact of $3.7 million; on a constant currency basis, revenue grew 15% organically. See the attached table for a description of non-GAAP financial measures and reconciliation of revenue excluding foreign currency exchange rate fluctuations.

Sequentially, revenue increased 3%, reflecting continued momentum exiting the year. Sales to U.S. customers represented 56% of total revenue compared with 54% in the fourth quarter of last year, with the remaining sales primarily generated in Europe, Canada and Asia-Pacific. The Company continues to benefit from its diversified geographic footprint and balanced exposure across end markets.

Market Performance:

   --  Industrial revenue increased 24%, driven by strengthening industrial 
      automation demand and improving order patterns, returning to more 
      normalized run rates. Additionally, strong demand for power quality 
      solutions supporting data center infrastructure provided meaningful 
      tailwinds, more than offsetting softer conditions in oil and gas. These 
      trends reflect continued alignment with long-term secular drivers, 
      including electrification, automation and energy efficiency. 
 
   --  Vehicle market sales rose 35%, primarily due to increased commercial 
      automotive shipments related to a transitioning model program. The 
      step-up in demand is not indicative of a new structural run rate. Sales 
      also benefited from strengthening construction and powersports demand, 
      which appear to have stabilized following prior softness. 
 
   --  Medical revenue increased 9%, supported by steady demand for surgical 
      instruments and continued traction in precision motion solutions for 
      medical applications. The Company remains well positioned in this market 
      given its engineering capabilities and long-standing customer 
      relationships. 
 
   --  Aerospace & Defense revenue declined 5%, reflecting the typically lumpy 
      nature of scheduled defense and aerospace program shipments. Demand 
      fundamentals remain intact, with solid underlying program activity, 
      partially offset by the M10 Booker Tank program cancellation announced 
      last quarter. The Company continues to view A&D as a strategic growth 
      vertical supported by long-cycle program visibility. 
 
   --  Distribution channel sales, while representing a smaller portion of 
      total revenue, were up 11%. 

Gross margin expanded 90 basis points year-over-year to 32.4%, driven by higher volumes, a favorable product mix, and continued operational efficiencies realized under the Company's Simplify to Accelerate NOW strategy. Sequentially, gross margin declined 90 basis points, reflecting a higher proportion of vehicle market sales during the quarter, which carry comparatively lower margins.

Operating costs and expenses were 24.5% of revenue, representing a 170 basis point improvement compared with the same period last year. The year-over-year reduction reflects operating leverage on increased volumes and ongoing savings initiatives. Sequentially, operating expenses as a percentage of revenue held consistent, primarily due to higher incentive compensation tied to the Company's strong full-year performance.

As a result, operating income increased 76% to $11.4 million, or 7.9% of revenue, compared with $6.4 million, or 5.3% of revenue, in the prior-year period, demonstrating significant operating margin expansion. Sequentially, operating income declined 7%, with operating margin decreasing 90 basis points, reflecting the combined impact of product mix and higher incentive compensation.

The effective income tax rate was 26.2% for the fourth quarter of 2025 compared with 22.6% in the prior-year period, primarily reflecting income mix and foreign withholding taxes.

Net income more than doubled to $6.4 million, or $0.38 per diluted share, compared with $3.0 million, or $0.18 per diluted share, in the prior-year period. Sequentially, net income was down marginally from $6.5 million, or $0.39 per diluted share. Adjusted net income, which excludes amortization of intangible assets related to acquisitions, acquisition and integration-related costs, restructuring and business realignment costs, and other non-recurring items, was $9.3 million, or $0.55 per diluted share. This represents an increase of 78% compared with $5.2 million, or $0.31 per diluted share, in the fourth quarter of 2024, and compares with $9.9 million, or $0.59 per diluted share, in the third quarter of 2025. See the attached tables for a description of non-GAAP financial measures and reconciliation table for Adjusted Net Income and Diluted Earnings per Share.

Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, acquisition and integration-related costs, restructuring and business realignment costs, and foreign currency gains/losses ("Adjusted EBITDA") was $19.0 million, or 13.3% of revenue, compared with $14.1 million, or 11.6% of revenue, in the prior-year period, and compares with $20.3 million, or 14.6% of revenue, in the third quarter of 2025. The Company believes that, when used in conjunction with measures prepared in accordance with U.S. generally accepted accounting principles, Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of its operating performance. See the attached table for a description of non-GAAP financial measures and reconciliation table for Adjusted EBITDA.

Full Year 2025 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue for the full year totaled $554.5 million, an increase of $24.5 million, or 5%, compared with the prior year. Foreign currency exchange rate fluctuations favorably impacted revenue by $6.5 million; on a constant currency basis, revenue increased 3% organically.

Growth was led by the Industrial market, which increased 8%, driven by continued traction in power quality solutions supporting data center infrastructure. Aerospace & Defense revenue also advanced 8%, reflecting solid program execution and sustained demand across defense and aerospace platforms. Medical revenue rose 5% on steady surgical instrument demand. Vehicle market sales declined 6% year-over-year, reflecting softer powersports conditions, partially offset by strength in commercial automotive and construction.

Sales to U.S. customers represented 55% of total revenue, consistent with the prior year, with the balance of sales primarily generated in Europe, Canada and Asia-Pacific.

Gross margin for the full year was 32.8%, an increase of 150 basis points compared with the prior year and a record level for a full-year period. The improvement was driven primarily by higher volumes, a favorable product mix, and continued benefits from the Company's Simplify to Accelerate NOW strategy.

Operating costs and expenses were 24.8% of revenue, compared with 25.6% last year, reflecting leverage on higher sales as well as ongoing savings and efficiencies generated through the Simplify initiatives. As a result, operating income increased 46% to $44.0 million, or 7.9% of sales, compared with $30.0 million, or 5.7% of sales, in the prior year.

Restructuring and business realignment costs totaled $4.0 million for the year. The Company had previously estimated total costs related to the Dothan transition at approximately $5.0 million; the lower actual spend reflects that the transition will continue into 2026.

Net income was $22.0 million, or $1.32 per diluted share, compared with $13.2 million, or $0.79 per diluted share. The effective tax rate was 23.3% in 2025 compared with 21.9% in 2024. The Company expects its income tax rate for the full year 2026 to be approximately 21% to 23%.

Excluding amortization of intangible assets related to acquisitions, business development costs and other non-recurring items, adjusted net income increased 47% to $36.3 million, or $2.17 per diluted share, compared with $24.7 million, or $1.49 per diluted share, in 2024.

Adjusted EBITDA was $76.9 million, and as a percentage of revenue was 13.9%, up 210 basis points.

Balance Sheet and Cash Flow Review

Cash and cash equivalents increased 13% to $40.7 million, compared with $36.1 million at year-end 2024, reflecting continued improvement in liquidity. Full-year cash provided by operating activities rose 35% to $56.7 million, up from $41.9 million in the prior year, driven by higher net income and improved working capital management.

Capital expenditures totaled $7.0 million in 2025, primarily supporting new customer programs, compared with $9.7 million in 2024. The Company expects 2026 capital expenditures to range between $10 million and $12 million.

Total debt declined to $180.4 million, representing a $9.9 million reduction from the sequential third quarter and a $43.8 million decrease since year-end 2024. Debt, net of cash, decreased to $139.7 million, resulting in a net debt-to-capitalization ratio of 31.7%.

The Company's leverage ratio, defined as total net debt divided by trailing twelve months Adjusted EBITDA, improved significantly to 1.82x from 3.01x at December 31, 2024. The bank leverage ratio, as defined under the Company's credit agreement and excluding foreign cash and certain other adjustments, was 2.34x at year-end, well within covenant requirements. See the attached table for a description of non-GAAP financial measures and reconciliation table for Total Net Debt and Leverage Ratio.

Orders and Backlog Summary ($ in thousands)

 
           Q4 2025   Q3 2025   Q2 2025   Q1 2025   Q4 2024 
           --------  --------  --------  --------  -------- 
Orders     $145,088  $133,119  $135,032  $137,622  $117,900 
Backlog    $232,925  $230,984  $236,586  $237,323  $230,788 
 

Fourth quarter orders increased 9% sequentially, reflecting steady demand across Industrial market applications, continued strength in Aerospace & Defense, and solid commercial automotive activity within the Vehicle market. On a year-over-year basis, orders rose 23%, driven by broad-based demand across end markets. Fourth quarter orders resulted in a book-to-bill ratio of 1.01, underscoring sustained order momentum. Foreign currency translation provided a favorable impact of $3.4 million compared with the prior-year period.

For full year 2025, orders totaled $550.9 million, an increase of $70.8 million or 15%, compared with 2024. Foreign currency translation provided a favorable impact of $6.4 million compared with the full year 2024.

The majority of the backlog is expected to convert to revenue within three to nine months, consistent with the Company's historical conversion patterns.

Conference Call and Webcast

The Company will host a conference call and webcast on Friday, March 6, 2026, at 10:00 am ET. During the conference call, management will review the financial and operating results and discuss Allient's corporate strategy and outlook. A question-and-answer session will follow.

To listen to the live call, dial (412) 634-6879. In addition, the webcast and slide presentation may be found at: www.allient.com/investors.

A telephonic replay will be available from 2:00 pm ET on the day of the call through Friday, March 20, 2026. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10205461 or access the webcast replay via the Company's website. A transcript will also be posted to the website once available.

About Allient Inc.

Allient (Nasdaq: ALNT) is a global engineering and manufacturing enterprise that develops solutions to drive the future of market-moving industries, including medical, life sciences, aerospace and defense, industrial automation, robotics, semi-conductor, transportation, agriculture, construction and facility infrastructure. A family of globally responsible companies, Allient takes a One-Team approach to "Connect What Matters" and provides the most robust, reliable, and high-value products and systems by utilizing its core Motion, Controls, and Power technologies and platforms.

Headquartered in Buffalo, N.Y., Allient employs more than 2,500 team members around the world. To learn more, visit www.allient.com.

Safe Harbor Statement

The statements in this news release that relate to future plans, events or performance are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements. Examples of forward-looking statements include, among others, statements the Company makes regarding expected savings from restructuring and simplifying actions, the cost of implementing such actions, operating results, expectations for the level of sales, the Company's belief that it has sufficient liquidity to fund its business operations, and expectations with respect to the conversion of backlog to sales. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of the Company's business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the pace of bookings relative to shipments, the ability to expand into new markets and geographic regions, the success in acquiring new business, the impact of changes in income tax rates or policies, commercial activity and demand across our and our customers' businesses, global supply chains, the prices of our securities and the achievement of our strategic objectives, the ability to attract and retain qualified personnel, the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward looking statements, whether as a result of new information, future events, or otherwise.

FINANCIAL TABLES FOLLOW

 
                          ALLIENT INC. 
           CONDENSED CONSOLIDATED STATEMENTS OF INCOME 
              (In thousands, except per share data) 
                           (Unaudited) 
 
                             For the three 
                              months ended     For the year ended 
                           ------------------  ------------------ 
                              December 31,        December 31, 
                           ------------------  ------------------ 
                             2025      2024      2025      2024 
                           --------  --------  --------  -------- 
Revenue                    $143,354  $122,010  $554,478  $529,968 
Cost of goods sold           96,934    83,636   372,769   364,277 
                            -------   -------   -------   ------- 
Gross profit                 46,420    38,374   181,709   165,691 
Operating costs and 
 expenses: 
    Selling                   6,267     6,027    24,524    25,310 
    General and 
     administrative          15,489    13,231    57,853    55,669 
    Engineering and 
     development              9,651     9,345    38,836    39,761 
    Acquisition and 
     integration-related 
     costs                        7       189        47       445 
    Restructuring and 
     business realignment 
     costs                      536        23     3,993     1,971 
    Amortization of 
     intangible assets        3,121     3,116    12,471    12,497 
                            -------   -------   -------   ------- 
Total operating costs and 
 expenses                    35,071    31,931   137,724   135,653 
                            -------   -------   -------   ------- 
Operating income             11,349     6,443    43,985    30,038 
Other expense, net: 
    Interest expense          2,587     3,089    13,175    13,296 
    Other expense 
     (income), net              112     (521)     2,076     (116) 
                            -------   -------   -------   ------- 
Total other expense, net      2,699     2,568    15,251    13,180 
                            -------   -------   -------   ------- 
Income before income 
 taxes                        8,650     3,875    28,734    16,858 
Income tax provision        (2,267)     (862)   (6,700)   (3,692) 
                            -------   -------   -------   ------- 
Net income                 $  6,383  $  3,013  $ 22,034  $ 13,166 
                            =======   =======   =======   ======= 
Basic earnings per share: 
    Earnings per share     $   0.38  $   0.18  $   1.32  $   0.80 
                            =======   =======   =======   ======= 
    Basic weighted 
     average common 
     shares                  16,701    16,581    16,669    16,529 
                            =======   =======   =======   ======= 
Diluted earnings per 
 share: 
    Earnings per share     $   0.38  $   0.18  $   1.32  $   0.79 
                            =======   =======   =======   ======= 
    Diluted weighted 
     average common 
     shares                  16,803    16,608    16,732    16,603 
                            =======   =======   =======   ======= 
 
 
                             ALLIENT INC. 
                CONDENSED CONSOLIDATED BALANCE SHEETS 
                 (In thousands, except per share data) 
 
                                                      December 31, 
                                                   ------------------- 
                                                     2025      2024 
                                                   --------  --------- 
Assets 
Current assets: 
    Cash and cash equivalents                      $ 40,705  $  36,102 
    Trade receivables, net of provision for 
     credit losses of $887 and $1,628 at December 
     31, 2025 and December 31, 2024, 
     respectively                                    88,775     78,774 
    Inventories                                     109,198    111,517 
    Prepaid expenses and other assets                14,759     11,187 
                                                    -------   -------- 
Total current assets                                253,437    237,580 
Property, plant, and equipment, net                  61,771     65,685 
Deferred income taxes                                10,509      9,116 
Intangible assets, net                               88,391     99,671 
Goodwill                                            134,332    131,789 
Operating lease assets                               21,030     23,748 
Other long-term assets                                8,125      8,192 
                                                    -------   -------- 
Total Assets                                       $577,595  $ 575,781 
                                                    =======   ======== 
Liabilities and Stockholders' Equity 
Current liabilities: 
    Accounts payable                               $ 28,433  $  27,156 
    Accrued liabilities                              40,890     30,221 
                                                    -------   -------- 
Total current liabilities                            69,323     57,377 
Long-term debt                                      180,389    224,177 
Deferred income taxes                                 3,241      3,642 
Pension and post-retirement obligations               1,239      1,667 
Operating lease liabilities                          16,431     19,417 
Other long-term liabilities                           5,517      4,647 
                                                    -------   -------- 
Total liabilities                                   276,140    310,927 
Stockholders' Equity: 
    Common stock, no par value, authorized 50,000 
     shares; 16,936 and 16,810 shares issued and 
     outstanding at December 31, 2025 and 
     December 31, 2024, respectively                113,936    111,024 
    Preferred stock, par value $1.00 per share, 
    authorized 5,000 shares; no shares issued or 
    outstanding                                          --         -- 
    Retained earnings                               197,046    177,013 
    Accumulated other comprehensive loss            (9,527)   (23,183) 
                                                    -------   -------- 
Total stockholders' equity                          301,455    264,854 
                                                    -------   -------- 
Total Liabilities and Stockholders' Equity         $577,595  $ 575,781 
                                                    =======   ======== 
 
 
                               ALLIENT INC. 
             CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
                              (In thousands) 
 
                                                  For the year ended 
                                            ------------------------------ 
                                             December 31,    December 31, 
                                                 2025            2024 
                                            --------------  -------------- 
Cash Flows From Operating Activities: 
Net income                                  $       22,034  $       13,166 
Adjustments to reconcile net income to net 
 cash provided by operating activities 
    Depreciation and amortization                   25,407          25,891 
    Deferred income taxes                          (1,795)         (2,353) 
    Provision for excess and obsolete 
     inventory                                       3,891           4,943 
    Stock-based compensation expense                 3,430           4,147 
    Debt issue cost amortization recorded 
     in interest expense                               648             534 
    Other                                              610           (119) 
    Changes in operating assets and 
     liabilities, net of acquisitions: 
        Trade receivables                          (7,893)           7,455 
        Inventories                                  3,318           7,358 
        Prepaid expenses and other assets          (2,709)           2,412 
        Accounts payable                               175        (12,755) 
        Accrued liabilities                          9,559         (8,829) 
                                                ----------      ---------- 
Net cash provided by operating activities           56,675          41,850 
 
Cash Flows From Investing Activities: 
    Consideration paid for acquisitions, 
     net of cash acquired                               --        (25,231) 
    Purchase of property and equipment             (6,989)         (9,683) 
                                                ----------      ---------- 
Net cash used in investing activities              (6,989)        (34,914) 
 
Cash Flows From Financing Activities: 
    Proceeds from issuance of long-term 
     debt                                               --          76,898 
    Principal payments of long-term debt 
     and finance lease obligations                (44,448)        (68,433) 
    Payment of contingent consideration                 --         (2,450) 
    Payment of debt issuance costs                    (44)         (3,154) 
    Dividends paid to stockholders                 (2,001)         (1,981) 
    Tax withholdings related to net share 
     settlements of restricted stock               (1,203)         (1,723) 
                                                ----------      ---------- 
Net cash used in financing activities             (47,696)           (843) 
Effect of foreign exchange rate changes on 
 cash                                                2,613         (1,892) 
                                                ----------      ---------- 
Net increase in cash and cash equivalents            4,603           4,201 
Cash and cash equivalents at beginning of 
 period                                             36,102          31,901 
                                                ----------      ---------- 
Cash and cash equivalents at end of period  $       40,705  $       36,102 
                                                ==========      ========== 
 

ALLIENT INC.

Reconciliation of Non-GAAP Financial Measures

(In thousands, Unaudited)

In addition to reporting revenue and net income, which are U.S. generally accepted accounting principle ("GAAP") measures, the Company presents Revenue excluding foreign currency exchange rate impacts, Organic revenue, EBITDA and Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, stock-based compensation expense, acquisition and integration-related costs, restructuring and business realignment costs, and foreign currency gains/losses), total net debt, and leverage ratio, which are non-GAAP measures.

The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not fully under management's control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period. Organic revenue is reported revenues adjusted for the impact of foreign currency and the revenue contribution from acquisitions.

The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company's operating performance and are a significant basis used by the Company's management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, acquisition and integration-related costs, restructuring and business realignment costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company's core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP. In addition to the performance measures identified above, we believe that total net debt and leverage ratio provide meaningful measures of liquidity and a useful basis for assessing our ability to fund our activities, including the financing of acquisitions and debt repayments. Total net debt is calculated as total debt less cash and cash equivalents. Leverage ratio is total net debt divided by adjusted EBITDA for the trailing twelve months.

The Company's calculation of Revenue excluding foreign currency exchange impacts for the three and twelve months ended December 31, 2025 is as follows:

 
                             Three Months Ended      Twelve Months Ended 
                             December 31, 2025        December 31, 2025 
                           ----------------------  ----------------------- 
Revenue as reported         $         143,354        $         554,478 
Less: Foreign currency 
 impact                                (3,659)                  (6,481) 
                               --------------      ---  -------------- 
Revenue excluding foreign 
 currency exchange 
 impacts                    $         139,695        $         547,997 
                               ==============      ===  ============== 
 

The Company's calculation of organic revenue for the three and twelve months ended December 31, 2025 is as follows:

 
 
                                Three months ended    Twelve months ended 
                                December 31, 2025      December 31, 2025 
                               --------------------  --------------------- 
Revenue change over prior 
 year                                   17.5%                   4.6% 
Less: Impact of acquisitions 
 and foreign currency                  (3.0)                  (1.4) 
                               -------------  -----  --------------  ----- 
  Organic revenue                       14.5%                   3.2% 
                               =============   ====  ============== ==== 
 

ALLIENT INC.

Reconciliation of Non-GAAP Financial Measures

(In thousands, Unaudited)

The Company's calculation of Adjusted EBITDA for the three and twelve months ended December 31, 2025 and 2024 is as follows:

 
 
                          Three months ended   Twelve months ended 
                             December 31,         December 31, 
                          -------------------  ------------------- 
                             2025      2024       2025      2024 
                          ----------  -------  ----------  ------- 
Net income as reported    $    6,383  $ 3,013  $   22,034  $13,166 
   Interest expense            2,587    3,089      13,175   13,296 
   Provision for income 
    tax                        2,267      862       6,700    3,692 
   Depreciation and 
    amortization               6,302    6,643      25,407   25,891 
                              ------   ------      ------   ------ 
EBITDA                        17,539   13,607      67,316   56,045 
   Stock-based 
    compensation 
    expense                      840      765       3,430    4,147 
   Acquisition and 
    integration-related 
    costs                          7      189          47      445 
   Restructuring and 
    business realignment 
    costs                        536       23       3,993    1,971 
   Foreign currency 
    loss/(gain)                  105    (464)       2,079     (83) 
                              ------   ------      ------   ------ 
Adjusted EBITDA           $   19,027  $14,120  $   76,865  $62,525 
                              ======   ======      ======   ====== 
 

The Company's calculation of Total Net Debt and Leverage Ratio as of December 31, 2025 and December 31, 2024 is as follows:

 
 
                                   December 31, 2025    December 31, 2024 
                                  -------------------  ------------------- 
Total debt                          $         180,389    $         224,177 
Less: cash and cash equivalents     $          40,705    $          36,102 
                                  ---  --------------  ---  -------------- 
Total net debt (Non-GAAP)           $         139,684    $         188,075 
 
Adjusted EBITDA (Non-GAAP)          $          76,865    $          62,525 
 
Leverage Ratio (Non-GAAP)                        1.82                 3.01 
 

ALLIENT INC.

Reconciliation of GAAP Net Income and Diluted Earnings per Share to

Non-GAAP Adjusted Net Income and Adjusted Diluted Earnings per Share

(In thousands, except per share data)

(Unaudited)

The Company's calculation of Adjusted net income and Adjusted diluted earnings per share for the three and twelve months ended December 31, 2025 and 2024 is as follows:

 
 
                                 For the three months ended 
                                        December 31, 
                             ---------------------------------- 
                                        Per               Per 
                                      diluted           diluted 
                              2025     share     2024    share 
                             ------  ---------  ------  ------- 
Net income as reported       $6,383  $    0.38  $3,013  $  0.18 
Non-GAAP adjustments, 
net of tax (1) 
   Amortization of 
    intangible assets -- 
    net                       2,391       0.14   2,387     0.14 
   Foreign currency loss / 
    (gain) -- net                80       0.01   (355)   (0.02) 
   Acquisition and 
    integration-related 
    costs -- net                  5         --     145     0.01 
   Restructuring and 
    business realignment 
    costs -- net                412       0.02      18       -- 
                              -----   --------   -----   ------ 
Non-GAAP adjusted net 
 income and adjusted 
 diluted earnings per 
 share                       $9,271  $    0.55  $5,208  $  0.31 
                              =====   ========   =====   ====== 
 
   Weighted average diluted 
    shares outstanding                  16,803           16,608 
 
 
____________________ 
(1)    Applies a blended federal, state, and foreign tax rate of 23% 
       applicable to the non-GAAP adjustments. 
 
 
 
                              For the twelve months ended 
                                      December 31, 
                          ------------------------------------ 
                                     Per                Per 
                                   diluted            diluted 
                             2025   share       2024   share 
                          -------  --------  -------  -------- 
Net income as reported    $22,034  $   1.32  $13,166  $   0.79 
Non-GAAP adjustments, 
net of tax (1) 
   Amortization of 
    intangible assets -- 
    net                     9,553      0.57    9,726      0.59 
   Foreign currency loss 
    / (gain) -- net         1,592      0.10     (64)        -- 
   Acquisition and 
    integration-related 
    costs -- net               36        --      341      0.02 
   Restructuring and 
    business realignment 
    costs -- net            3,059      0.18    1,510      0.09 
                           ------   -------   ------   ------- 
Non-GAAP adjusted net 
 income and adjusted 
 diluted earnings per 
 share                    $36,274  $   2.17  $24,679  $   1.49 
                           ======   =======   ======   ======= 
 
   Weighted average 
    diluted shares 
    outstanding                      16,732             16,603 
 
 
____________________ 
(1)    Applies a blended federal, state, and foreign tax rate of 23% 
       applicable to the non-GAAP adjustments. 
 

Adjusted net income and diluted EPS are defined as net income as reported, adjusted for certain items, including amortization of intangible assets and unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in the United States, and may not be comparable to the measure as used by other companies. Nevertheless, the Company believes that providing non-GAAP information, such as adjusted net income and diluted EPS are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current quarter's and current year's net income and diluted EPS to the historical periods' net income and diluted EPS.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260305746391/en/

 
    CONTACT:    Investor Contacts: 

Craig P. Mychajluk / Deborah K. Pawlowski

Alliance Advisors IR

716-843-3832 / 716-843-3908

cmychajluk@allianceadvisors.com / dpawlowski@allianceadvisors.com

 
 

(END) Dow Jones Newswires

March 05, 2026 16:23 ET (21:23 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment